Skip to main
CALT
CALT logo

Calliditas Therapeutics AB (CALT)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CALT Stock

About Calliditas Therapeutics AB (CALT)

Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropat...read more
Market cap$1.07B
Today's volume
Revenue (TTM)
Avg. daily volume7.26K
EBITDA (TTM)
Open
Price / earnings ratio-23.64x
Today's range
Debt / equity
52 week range$15.25 - $43
5 year debt / equity81.1x
Beta (LTM)0.02x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 13, 2024
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for CALT stock is $1.08B

The current P/E ratio for CALT stock is -23.64

The 52-week high for CALT stock is $43. The current CALT stock price $undefined is 100.00% below its 52-week high

The 52-week low for CALT stock is $15.25. The current CALT stock price $undefined has increased 100.00% from its 52-week low

No, the CALT stock does not pay dividends to its shareholders

How to buy CALT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CALT stock

    Navigate to the Explore page. Then, type CALT into the search bar. When you see CALT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CALT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Calliditas Therapeutics AB Stock Earnings

The value each CALT share was expected to gain vs. the value that each CALT share actually gained.

CALT (CALT) reported Q2 2024 earnings per share (EPS) of -$0.16, missing estimates of -$0.10 by 60.00%. In the same quarter last year, CALT's earnings per share (EPS) was -$0.33. CALT is expected to release next earnings on 08/13/2024, with an earnings per share (EPS) estimate of $0.

Buy CALT Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.